OK... so Cavatak is valuable to Merck and BMS.
What are the chances a separate agreement exists between both those parties whereby Merck makes the formal offer, BMS agrees not to engage in a bidding war, they share equally in the offer price .... and both gain access to Cavatak?
Ann: Ceasing to be a substantial holder from MS, page-45
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)